Kelly Childress Lange is named as a lobbyist on federal disclosure filings for 14 clients through East End Group, LLC and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Tariff (miscellaneous tariff bills), Manufacturing and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| OTW HOLDINGS LLC | CGCN GROUP, LLC | Q3 2026 | Health Issues |
| PARTNER THERAPEUTICS, INC. | CGCN GROUP, LLC | Q3 2026 | Defense, Health Issues |
| ALVOTECH | CGCN GROUP, LLC | Q3 2026 | Health Issues, Tariff (miscellaneous tariff bills), Manufacturing |
| FRESENIUS KABI USA, LLC | CGCN GROUP, LLC | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Tariff (miscellaneous tariff bills) |
| PARTNER THERAPUTICS | EAST END GROUP, LLC | Q3 2026 | Health Issues |
| BAVARIAN NORDIC INC. | EAST END GROUP, LLC | Q3 2026 | Health Issues |
| HEALTHY MOMS, HEALTHY BABIES AMERICA | CGCN GROUP, LLC | Q3 2026 | Health Issues |
| HEARTLAND ACTION | CGCN GROUP, LLC | Q2 2026 | Health Issues |
| FRESENIUS KABI | EAST END GROUP, LLC | Q2 2026 | Tariff (miscellaneous tariff bills), Health Issues, Manufacturing |
| LONGHORN | EAST END GROUP, LLC | Q2 2026 | Health Issues |
| ALVOGEN | EAST END GROUP, LLC | Q2 2026 | Manufacturing, Health Issues, Tariff (miscellaneous tariff bills) |
| SEQIRUS | EAST END GROUP, LLC | Q2 2026 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | EAST END GROUP, LLC | Q1 2026 | Health Issues |
| GLAXOSMITHKLINE | EAST END GROUP, LLC | Q2 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 12 | 2 |
| 2025 | 8 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 4 | $12K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Kelly Childress Lange. See the Capitol Clarity rankings and method.